Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 141, Issue -, Pages 1-12Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2019.06.004
Keywords
Microbiome; Cancer therapeutics; Carcinogenesis
Categories
Ask authors/readers for more resources
The human microbiome is an emerging target in cancer development and therapeutics. It may be directly oncogenic, through promotion of mucosa] inflammation or systemic dysregulation, or may alter anti-cancer immunity/therapy. Microorganisms within, adjacent to and distant from tumors may affect cancer progression, and interactions and differences between these populations can influence the course of disease. Here we review the microbiome as it pertains to cancer for clinicians. The microbiota of cancers including colorectal, pancreas, breast and prostate are discussed. We examine omics technologies, microbiota associated with tumor tissue and tumor-site fluids such as feces and urine, as well as indirect effects of the gut microbiome. We describe roles of the microbiome in immunotherapy, and how it can be modulated to improve cancer therapeutics. While research is still at an early stage, there is potential to exploit the microbiome, as modulation may increase efficacy of treatments, reduce toxicities and prevent carcinogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available